financetom
INGR
financetom
/
Consumer Staples
/
INGR
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Ingredion IncorporatedINGR
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
8.32B
Revenue (ttm)
7.43B
Net Income (ttm)
647.00M
Shares Out
64.19M
EPS (ttm)
9.71
PE Ratio
13.17
Forward PE
11.57
Dividend
$3.20 (2.50%)
Ex-Dividend Date
Apr 1, 2025
Volume
132,171
Open
127.88
Previous Close
127.51
Day's Range
126.41 - 129.70
52-Week Range
109.51 - 155.44
Beta
0.71
Analysts
Hold
Price Target
152.60 (+17.79%)
Earnings Date
May 7, 2025
Description >

Ingredion Incorporated, together with its subsidiaries, produces and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa.

The company offers starch products for use in a range of processed foods; cornstarch; specialty paper starches for enhanced drainage, fiber retention, oil and grease resistance, improved printability, and biochemical oxygen demand control; starches and specialty starches for textile industry; industrial starches are used in the production of construction materials, textiles, adhesives, pharmaceuticals, and cosmetics, as well as in mining and water filtration; and specialty industrial starches for use in biomaterial applications, including biodegradable plastics, fabric softeners and detergents, hair and skin care applications, dusting powders for surgical gloves, and in the production of glass fiber and insulation.

It also provides sweetener products comprising glucose syrups, high maltose syrup, high fructose corn syrup, dextrose, polyols, maltodextrin, glucose syrup solids, and non-genetically modified organism syrups for use in food and beverage products, such as baked goods, snack foods, canned fruits, condiments, candy and other sweets, dairy products, ice cream, jams and jellies, prepared mixes, table syrups, soft drinks, fruit-flavored drinks, and others.

In addition, the company refined corn oil, corn gluten feed, and corn gluten meal; and other products, including fruit and vegetable products, such as concentrates, purees, and essences, as well as pulse proteins and hydrocolloids systems and blends.

The company was formerly known as Corn Products International, Inc. and changed its name to Ingredion Incorporated in June 2012.

Ingredion Incorporated was founded in 1906 and is headquartered in Westchester, Illinois.

Latest News >
AirBaltic IPO could be pushed back until early 2026, CEO says
AirBaltic IPO could be pushed back until early 2026, CEO says
Jan 13, 2025
DUBLIN, Jan 13 (Reuters) - AirBaltic's initial public offering (IPO) could be pushed back until early 2026, the Latvian airline's chief executive said on Monday. CEO Martin Gauss said the airline was still looking for a pre-IPO strategic investor ahead of the offering that was initially planned for last year. ...
Biden admin delays enforcement of order blocking Nippon Steel, US Steel deal, companies say
Biden admin delays enforcement of order blocking Nippon Steel, US Steel deal, companies say
Jan 13, 2025
WASHINGTON (Reuters) -The Biden administration delayed until June an order for Nippon Steel to abandon its $14.9 billion bid for U.S. Steel, the companies said on Saturday, giving them some time to revive the politically contentious deal. President Joe Biden blocked the acquisition on national security grounds on Jan. 3, and Treasury Secretary Janet Yellen said this week the proposed...
Molecular Partners Expands Clinical Collaboration With Orano Med to Add 6 Targeted Alpha Radio-Therapies for Cancer
Molecular Partners Expands Clinical Collaboration With Orano Med to Add 6 Targeted Alpha Radio-Therapies for Cancer
Jan 13, 2025
05:26 AM EST, 01/13/2025 (MT Newswires) -- Molecular Partners AG ( MOLN ) expanded its strategic collaboration with Orano Med to include the development of an additional six targeted alpha radio-therapies for cancer, the companies said Sunday. The companies entered into an initial agreement in January 2024 to co-develop four programs. Under the expanded collaboration, Molecular Partners ( MOLN )...
Medical Properties Trust Prioritizes California Investments in Prospect Medical Group Chapter 11
Medical Properties Trust Prioritizes California Investments in Prospect Medical Group Chapter 11
Jan 13, 2025
05:01 AM EST, 01/13/2025 (MT Newswires) -- Medical Properties Trust ( MPW ) said Sunday that it is prioritizing the protection of its investments in Prospect Medical Group's California hospitals as Prospect commences Chapter 11 bankruptcy restructuring. While Prospect's California facilities have reported volume growth and improved coverage trends in 2024, its overall liquidity has been adversely impacted by stalled...
Copyright 2023-2025 - www.financetom.com All Rights Reserved